Opendata, web and dolomites

In-Cytes SIGNED

IN-CYTES A HIGH-DENSITY MICROELECTRODE ARRAY PLATFORM FOR LARGE-SCALE INTRACELLULAR FUNCTIONAL ASSAYS

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 In-Cytes project word cloud

Explore the words cloud of the In-Cytes project. It provides you a very rough idea of what is the project "In-Cytes" about.

grant    direct    start    physiological    estimate    cure    employment    combining    cytes    first    bio    opportunity    larger    continue    expert    platform    pharmacy    swiss    business    technologies    neurodegenerative    parkinson    brain    interference    initial    drugs    recruitment    ag    brand    limited    skills    innovative    either    software    turn    contrast    electrophysiological    intracellular    cells    resolution    barriers    featuring    innovation    lacking    relatively    overcome    multidisciplinary    small    bioassays    platforms    companies    nerve    salary    radically    mxw    basic    minimum    career    hardware    preclinical    thousands    public    neural    alzheimer    company    enterprise    quantifying    neurons    visibility    discovery    physiology    disorders    throughput    perceived    diseases    drug    microfabrication    engineering    connectivity    envisaged    electrophysiology    maxwell    prototype    spatial    expertise    indirect    academic    compete    neuroscience    industrial    budget    unknown    biosystems    data    associate    poor   

Project "In-Cytes" data sheet

The following table provides information about the project.

Coordinator
MAXWELL BIOSYSTEMS AG 

Organization address
address: ALBISRIEDERSTRASSE 253
city: ZURICH
postcode: 8047
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 135˙500 €
 EC max contribution 135˙500 € (100%)
 Programme 1. H2020-EU.2.3.2.2. (Enhancing the innovation capacity of SMEs)
 Code Call H2020-INNOSUP-2019-02
 Funding Scheme CSA
 Starting year 2019
 Duration (year-month-day) from 2019-10-15   to  2020-10-14

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MAXWELL BIOSYSTEMS AG CH (ZURICH) coordinator 135˙500.00

Map

 Project objective

MaxWell Biosystems AG (MxW) is a Swiss public limited company (AG) who developed electrophysiological platforms (hardware-software-bioassays) for basic research and drug testing on nerve cells. MxW’s aim is to develop In-Cytes, a radically innovative electrophysiology platform to assess neural connectivity for preclinical drug discovery for brain diseases. In contrast to the state-of-the-art technologies for quantifying neural connectivity, which either estimate indirect connectivity or feature poor spatial resolution, In-Cytes can measure physiological direct neural intracellular connectivity among thousands of neurons. This directly addresses the industrial need in pharmacy for neural connectivity bioassays, featuring high-throughput and minimum interference with neurons’ physiology for the development of effective drugs to cure neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases.

The proposed recruitment of an Innovation Associate will have significant impact on the business opportunities of MxW by bringing in lacking expertise for the development of In-Cytes. The envisaged grant will help to overcome the recruitment barriers of being a relatively unknown, small start-up enterprise that cannot compete with larger companies due to limited visibility, brand awareness, (perceived) career opportunities, salary and recruitment budget.

The development of In-Cytes requires the employment of an academic expert with a multidisciplinary set of skills combining knowledge in neuroscience, microfabrication and data analysis. In turn, the innovation associate will have the opportunity to become an expert in the emerging field of bio-engineering. It is in the interest of the company to continue the employment after the initial year in order to develop the first prototype of In-Cytes into an industrial end product.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IN-CYTES" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IN-CYTES" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.2.2.)

KAMINLER (2020)

KAM and Innovation services for SMEs in Lombardia and Emilia-Romagna

Read More  

ICKEAM-5 (2020)

Establishing services enhancing the innovation management capacity of SME's in the Enterprise Europe Network

Read More  

H2020 Armenia (2020)

Provision of innovative support services to Armenian SMEs which potential for growth and innovation development.

Read More